Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Saabye

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
ACS Omega|January 6, 2025
Combining Fundamental Kinetics and Standard Alkylation Assays to Prioritize Lead-Like KRAS G12C InhibitorsAlexandra Frommlet, Lan K Nguyen, Matt Saabye, et al.
ACS Omega|March 31, 2025
Correction to "Combining Fundamental Kinetics and Standard Alkylation Assays to Prioritize Lead-like KRAS G12C Inhibitors"Alexandra Frommlet, Lan K Nguyen, Matt Saabye, et al.
Journal of Medicinal Chemistry|March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12CNicholas F Endres, Steven Do, Rana Mroue, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
ACS Omega|January 6, 2025
Combining Fundamental Kinetics and Standard Alkylation Assays to Prioritize Lead-Like KRAS G12C InhibitorsAlexandra Frommlet, Lan K Nguyen, Matt Saabye, et al.
ACS Omega|March 31, 2025
Correction to "Combining Fundamental Kinetics and Standard Alkylation Assays to Prioritize Lead-like KRAS G12C Inhibitors"Alexandra Frommlet, Lan K Nguyen, Matt Saabye, et al.
Journal of Medicinal Chemistry|March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12CNicholas F Endres, Steven Do, Rana Mroue, et al.
Pageof 1